PTC Therapeutics Inc Call to Review Topline Results from Study 041 of Translarna™ (Ataluren) Transcript
Good day, and thank you for standing by. Welcome to the Translarna (Ataluren) Study 041 Topline Results Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions). I'd now like to hand the conference over to your speaker today, Kylie O'Keefe, SVP of Global Corporate and Commercial Strategy. Please go ahead.
' -
Good morning, everyone, and thank you for joining us today for the Study 041 Results Call. Joining me on today's call is our Chief Executive Officer, Dr. Stuart Peltz. Slides are available on the Investors section of the website for you to follow along during the presentation today.
I will now pass the call over to our Chief Executive Officer, Stuart Peltz. Stu?
Thanks, Kylie. And thank you all for joining us today. We're excited to share with you results of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |